Article
Identification of the transforming <i>STRN-ALK</i> fusion as a potential therapeutic target in the aggressive forms of thyroid cancer
3 Feb 2014
Abstract excerpt
Thyroid cancer is a common endocrine malignancy that encompasses well-differentiated as well as dedifferentiated cancer types. The latter tumors have high mortality and lack effective therapies. Using a paired-end RNA-sequencing approach, we report the discovery of rearrangements involving the anaplastic lymphoma kinase (ALK) gene in thyroid cancer. The most common of these involves a fusion between ALK and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
